Yaz/Yasmin Teleseminar

Not an AAJ Member?

Join today to have access to all of the Legal Education AAJ has to offer!

Order from Playback Now!

You can purchase this seminar in high-quality audio or video CD/DVD or online access. Build your resource library or share with your office. Recordings may be accepted for MCLE credit in your state. Visit AAJ's online audio and video provider Playback Now »

For additional assistance
Please call 800.241.7785

November 10, 2011

Search the AAJ Exchange for materials from this education program »

Cosponsored by the Yaz/Yasmin Litigation Group

Background
October 2011 FDA Drug-Safety Report: "Combined Hormonal Contraceptives (CHCs) and the Risk of Cardiovascular Disease Endpoints"

May 2011 FDA Safety Communication

Moderator Instructions
Michael A. London, NY
Daniel S. Robinson, CA

Status of the Litigation
   Michael A. London, NY
   Daniel S. Robinson, CA

Lidegaard & Kaiser Studies
   Donald C. Arbitblit, CA
   Gary J. Douglas, NY

Gallbladder Update
   Cynthia L. Garber, CA
   Daniel C. Burke, NY

FDA/ Advisory Committee (Ad-Comm)
Paul J. Pennock, NY
Seth A. Katz, CO

Question and Answer Session